References
- Goodnough LT, Shuck M., Risks J. options and informed consent for blood transfusion in elective surgery. Am J Surg 1990; 159: 602–9
- Seidl S., Kuhnl P. Transmission of diseases by blood transfusion. World J Surg 1987; 11: 30–5
- Walker H. R. Special report: transfusion risks. Am J Clin Pathol 1987; 88: 374–8
- NIH Consensus Development Conference. Perioperative red cell transfusion. J Am Med Assoc 1988; 260: 2700–3
- Surgenor M. D. The patient's blood is the safest blood (editorial). N Engl J Med 1987; 26: 542–4
- American Medical Association. Autologous blood transfusions. Council on Scientific Affairs. Jama 1986; 256: 2378–80
- Haugen K. R., Hill G. E. A large-scale autologous blood program in a community hospital. A contribution to the community's blood supply. JAMA 1987; 257: 1211–4
- Mercuriali F., Inghilleri G., Biffi E., Colotti M. T., Vinci A. Autologous blood: a safe alternative for surgical patients. Trans Medica Europe Limited, NBV House, Eastbourne, UK 1989; 144–5
- Toy T. P., Strauss R. G., Stehling C. L., et al. Predeposited autologous blood for elective surgery. A national multicenter study. N Eng J Med 1987; 316: 517–20
- Williamson R. K., Taswell H. F. Intraoperative blood salvage: a review. Transfusion 1991; 31: 662–75
- Goodnough T. L., Wasman J., Corlucci K., Chernosky A. Limitations to donating adequate autologous blood prior to elective orthopedic surgery. Arch Surg 1989; 124: 494–6
- Pool R. Slow going for blood substitutes. Science 1990; 250: 1655–1656
- Mukherji B., Sloviter HA. A stable perfluorochemical blood substitute. Transfusion 1991; 31: 324–326
- Riess I. G. Fluorocarbon-based in vivo oxygen transport and delivery systems. Vox Sang 1991; 61: 225–239
- Goodnough T. L. Erythropoietin as a pharmacologic alternative to blood transfusion in the surgical patient. Transfus Med Rev 1990; 4: 228–96
- Levine A. E., Gould S. A., Rosen A. L., et al. Perioperative recombinant human erythropoietin. Surgery 1989; 106: 432–8
- Mercuriali F., Biffi E., Inghilleri G., Vinci A. Review a the role of preoperative autologous blood donation and intraoperative blood salvage. Erythropoiesis 1990; 1: 47–55
- Zanjani D. E., Ascensao J. L. Erythropoietin. Transfusion 1989; 29: 46–57
- Goodnough T. L., Rudnick S., Price T. H., et al. Increased preoperative collection of autologous blood with recombinant human eythropoietin therapy. N Engl J Med 1989; 321: 1163–8
- Mercuriali F., Biffi E., Inghilleri G., Vinci A. Low hematocrit: limiting factor in autologous blood predonation program. Transfusion in Europe, D. Castelli, B. Genetet, B. Habibi, U. Nydegger. ISBT, Paris 1989; 291–8
- Goodnough T. L., Brittenham M. G. Limitations of the erythropoietic response to serial plebotomy: implications for autologous blood donor programs. J Lab Clin Med 1990; 155: 28–35
- Kickler S. T., Spivak L. J. Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. JAMA 1988; 260: 65–7
- Mercuriali F., Zanella A., Barosi G., Inghilleri G., Biffi E., Vinci A., Colotti MT. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1990; 33: 55–60